These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 19696696)

  • 21. [Effect of the polymorphism of the angiotensin-converting enzyme gene on the drug treatment in patients with chronic heart failure].
    Huang WY; Sun M; Zhou HY; Pei ZF; Yang TL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):686-9. PubMed ID: 16114558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insertion/Deletion polymorphism of Angiotensin-converting enzyme as a risk factor for chronic allograft nephropathy.
    Fedor R; Asztalos L; Löcsey L; Szabó L; Mányiné IS; Fagyas M; Lizanecz E; Tóth A
    Transplant Proc; 2010; 42(6):2304-8. PubMed ID: 20692468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of the DD genotype and development of Japanese type 2 diabetic nephropathy.
    Gohda T; Makita Y; Shike T; Kobayashi M; Funabiki K; Haneda M; Kikkawa R; Watanabe T; Baba T; Yoshida H; Tomino Y
    Clin Nephrol; 2001 Dec; 56(6):475-80. PubMed ID: 11770799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The relationship between polymorphism of angiotensin converting enzyme gene and cough caused by angiotensin converting enzyme inhibitors].
    Yang SM; He QY; Miao YD
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Apr; 26(4):203-5. PubMed ID: 12901825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relationship of the disease severity with ACE gene polymorphism and serum ACE activity in preterm infants].
    Han TY; Li ZL; Ye HM
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Dec; 10(6):693-6. PubMed ID: 19102831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Association between angiotensin converting enzyme I/D polymorphism and high-sensitivity C-reactive protein in type 2 diabetic patients with atherosclerosis treated with ramipril].
    Wang L; Zhou YL; Lin SG
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):691-5. PubMed ID: 15958311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control study.
    Ay C; Bencur P; Vormittag R; Sailer T; Jungbauer C; Vukovich T; Mannhalter C; Pabinger I
    Thromb Haemost; 2007 Oct; 98(4):777-82. PubMed ID: 17938801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin converting enzyme genotype and chronic allograft nephropathy in protocol biopsies.
    Hueso M; Alía P; Moreso F; Beltrán-Sastre V; Riera L; González C; Navarro MA; Grinyó JM; Navarro E; Serón D
    J Am Soc Nephrol; 2004 Aug; 15(8):2229-36. PubMed ID: 15284309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin-converting enzyme gene polymorphism and the progression rate of focal segmental glomerulosclerosis in Iranian children.
    Gheissari A; Salehi M; Dastjerdi SB; Jahangiri M; Hooman N; Otookesh H; Merikhipour A; Ajir A; Foroughmand A; Khatami S; Shahidi S; Atapour A; Seirafian S; Naeini AE
    Nephrology (Carlton); 2008 Dec; 13(8):708-11. PubMed ID: 19076285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Polymorphism of the ACE gene, structural-functional state of the left ventricle in patients with post-infarction cardiac failure and effects of the ACE-inhibitor Perindopril].
    Tereshchenko SN; Demidova IV; Kobalava ZhD; Moiseev VS
    Ter Arkh; 2002; 74(4):56-8. PubMed ID: 12043242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphism, medical therapy and sequential cardiac function in patients with heart failure.
    Cuoco MA; Pereira AC; Mota Gde F; Krieger JE; Mansur AJ
    Arq Bras Cardiol; 2008 Apr; 90(4):252-6. PubMed ID: 18516385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased cardiovascular risk in long-term hemodialysis patients carrying deletion allele of ACE gene polymorphism.
    Ishimitsu T; Tsukada K; Ohta S; Inada H; Minami J; Ono H; Matsuoka H
    Am J Kidney Dis; 2004 Sep; 44(3):466-75. PubMed ID: 15332219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of implantable defibrillator therapy with angiotensin-converting enzyme deletion/insertion polymorphism.
    Bedi MS; Postava LA; Murali S; Macgowan GA; Mathier M; McNamara DM; London B
    J Cardiovasc Electrophysiol; 2004 Oct; 15(10):1162-6. PubMed ID: 15485441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effects of ACE inhibitor treatment and ACE gene polymorphism on erythropoiesis in chronic hemodialysis patients].
    Hatano M; Yoshida T; Mimuro T; Kimata N; Tsuchiya K; Sanaka T; Nihei H
    Nihon Jinzo Gakkai Shi; 2000 Oct; 42(8):632-9. PubMed ID: 11195399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation between angiotensin-converting enzyme I/D gene polymorphism and pulse pressure in patients with a first anterior acute myocardial infarction.
    Oztürk O; Oztürk U
    Anadolu Kardiyol Derg; 2009 Feb; 9(1):9-14. PubMed ID: 19196567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacoeconomic analysis of angiotensin-converting enzyme inhibitors in type 2 diabetes: a Markov model.
    Campbell HM; Boardman KD; Dodd MA; Raisch DW
    Ann Pharmacother; 2007 Jul; 41(7):1101-10. PubMed ID: 17609233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
    Atthobari J; Asselbergs FW; Boersma C; de Vries R; Hillege HL; van Gilst WH; Gansevoort RT; de Jong PE; de Jong-van den Berg LT; Postma MJ;
    Clin Ther; 2006 Mar; 28(3):432-44. PubMed ID: 16750458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of angiotensin-converting enzyme (ACE) gene insertion-deletion polymorphism with spondylarthropathies.
    Shehab DK; Al-Jarallah KF; Al-Awadhi AM; Al-Herz A; Nahar I; Haider MZ
    J Biomed Sci; 2008 Jan; 15(1):61-7. PubMed ID: 17713861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.
    Palmer AJ; Valentine WJ; Chen R; Mehin N; Gabriel S; Bregman B; Rodby RA
    Nephrol Dial Transplant; 2008 Apr; 23(4):1216-23. PubMed ID: 18359872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of angiotensin-converting enzyme gene polymorphism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure.
    Tang WH; Vagelos RH; Yee YG; Fowler MB
    Am Heart J; 2004 Nov; 148(5):889-94. PubMed ID: 15523323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.